Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
J Nutr Biochem
; 97: 108787, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1253236
ABSTRACT
The outbreak of mysterious pneumonia at the end of 2019 is associated with widespread research interest worldwide. The coronavirus disease-19 (COVID-19) targets multiple organs through inflammatory, immune, and redox mechanisms, and no effective drug for its prophylaxis or treatment has been identified until now. The use of dietary bioactive compounds, such as phenolic compounds (PC), has emerged as a putative nutritional or therapeutic adjunct approach for COVID-19. In the present study, scientific data on the mechanisms underlying the bioactivity of PC and their usefulness in COVID-19 mitigation are reviewed. In addition, antioxidant, antiviral, anti-inflammatory, and immunomodulatory effects of dietary PC are studied. Moreover, the implications of digestion on the putative benefits of dietary PC against COVID-19 are presented by addressing the bioavailability and biotransformation of PC by the gut microbiota. Lastly, safety issues and possible drug interactions of PC and their implications in COVID-19 therapeutics are discussed.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Phenols
/
Anti-Inflammatory Agents, Non-Steroidal
/
Dietary Supplements
/
Gastrointestinal Microbiome
/
COVID-19
/
Antioxidants
Topics:
Traditional medicine
Limits:
Animals
/
Humans
Language:
English
Journal:
J Nutr Biochem
Journal subject:
Biochemistry
/
Nutritional Sciences
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS